Dermatology

Investigational treatment PRN1008 demonstrated efficacy in this difficult-to-treat condition.

This extension study investigated the long-term efficacy and safety of tildrakizumab for patients with plaque psoriasis.

Results from the reSURFACE 1 phase 3 trial shows the biologic is beneficial to patient rates of anxiety, pain, and depression.

Patrick Burnett shares about the secondary endpoints and safety data of the CAMP 1 & 2 clinical trials.

The phase 2 Believe-PV study observed few adverse events in patients with pemphigus vulgaris.

Patrick Burnett reports impressive topline results from the CAMP 1 & 2 studies of investigational treatment VP-102.

Though there are few treatments for pemphigus vulgaris, a rare disease, the Believe-PV trial of PRN1008 raises the possibility of a new, better option.

Investigators assessed patients’ scores for body surface area, static Physician Global Assessments, and Dermatology QoL Index at 1 month post-index, and at three-month intervals both pre- and post-index.

Compared to standard cleansers and moisturizers, natural versions for sensitive skin provided benefits to patients with rosacea who were also taking prescription treatments.

In this analysis, brodalumab was successful in treating patients who had a psoriasis diagnosis for

New data from AAD show the recently-approved biologic is among the most cost-saving therapies in year 2 of treatment, and beyond.

Investigators sought to evaluate the efficacy, safety, psychosocial impact, quality of life, adherence to and satisfaction with the treatment of dupilumab and add-on treatment.

An internist’s perspective on which sessions to attend, from melanoma to inflammatory diseases to cosmetic procedures.

A meta-analysis of studies found that treatment with platelet-rich plasma improves androgenetic alopecia, scarring, and other dermatologic conditions.

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

Compared to a short time of breastfeeding or none, children exclusively breastfed for ≥3 months were less likely to have continued eczema at 6 years old.

The biologic's indications for inflammatory diseases are greatly varied and still developing, and it owes some of that to recent advances in disease prognosis.

The EPIT skin patch is still seeking indication as the first peanut allergy desensitization therapy to reach the market.

The ointment, which contains 3% CBD and 3% THC, will be tested for the treatment of psoriasis in an upcoming phase 2 trial.

Hilary Baldwin, MD, debunks the myths behind the nodular acne therapy she claims is a miracle drug.

Overall antibiotic prescriptions have dropped, but short-term postoperative prescriptions have increased in recent years.

Medical students’ perceptions of the barriers to applying for a dermatology residency vary based on race, ethnicity, and socioeconomic background.

The phase 3 CAMP-1 and CAMP-2 clinical trials evaluating VP-102 for the treatment of molluscum contagiosum demonstrated clinical and statistical significance.